RxDoctor Payments Data

Lacie Asher

Family · Burley, IDNPI 1609107176

Payments from drug & device makers

$1,084in general payments, 2019–2025

Across 58 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$570
  • Supernus Pharmaceuticals, Inc.$127
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$89
  • Upsher-smith Laboratories LLC$66
  • Alkermes, Inc.$47
  • Johnson & Johnson$30
  • plus $155 from 8 others

What the payments were for

  • Food & beverage$1,084100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,084 in reported general payments places this provider in the 70th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$12,515
Medicare patients
24
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate32$98,828
VraylarCariprazine Hcl33$43,635
PerserisRisperidone11$28,524
LinzessLinaclotide35$18,388
BelbucaBuprenorphine Hcl19$14,753
Paliperidone ErPaliperidone27$14,552
TrulicityDulaglutide15$14,042
Aripiprazole37$8,315
NamzaricMemantine Hcl/Donepezil Hcl14$7,736
VyvanseLisdexamfetamine Dimesylate21$7,707
Atomoxetine Hcl60$6,444
Advair HfaFluticasone Propion/Salmeterol14$5,882
TrintellixVortioxetine Hydrobromide12$5,778
Bromocriptine Mesylate21$4,962
Dronabinol14$3,965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$30$98,82832 claims
AbbVieVraylar, Linzess, Namzaric$570$69,75982 claims
Lilly USA, LLCTrulicity, Olanzapine$24$15,95035 claims
Upsher-smith Laboratories LLCTopiramate$66$1,26598 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 809 family providers in Idaho.

Other family in Burley

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →